SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-08-000770
Filing Date
2008-02-25
Accepted
2008-02-25 17:03:28
Documents
6
Period of Report
2008-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w50357e8vk.htm 8-K 16339
2 EX-10.1 w50357exv10w1.htm EX-10.1 177050
3 EX-10.2 w50357exv10w2.htm EX-10.2 94065
4 EX-10.3 w50357exv10w3.htm EX-10.3 43219
5 EX-10.4 w50357exv10w4.htm EX-10.4 11923
6 GRAPHIC w50357w5035700.gif GRAPHIC 10620
  Complete submission text file 0000950133-08-000770.txt   358961
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 08640141
SIC: 2836 Biological Products, (No Diagnostic Substances)